Tamoxifen
Tamoxifen is used for treating breast cancer that has spread to other sites of the body.
| Product dosage: 20mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.72 | $43.00 (0%) | 🛒 Add to cart |
| 90 | $0.67 | $64.50 $60.00 (7%) | 🛒 Add to cart |
| 120 | $0.63 | $86.00 $76.00 (12%) | 🛒 Add to cart |
| 180 | $0.61 | $129.00 $109.00 (16%) | 🛒 Add to cart |
| 270 | $0.59 | $193.50 $159.00 (18%) | 🛒 Add to cart |
| 360 | $0.58
Best per pill | $258.00 $209.00 (19%) | 🛒 Add to cart |
Synonyms
| |||
Similar products
More info:
Paroxetine: Restore Serotonin Balance for Lasting Mental Wellness
Paroxetine is a selective serotonin reuptake inhibitor (SSRI) indicated for the management of major depressive disorder, obsessive-compulsive disorder, panic disorder, social anxiety disorder, generalized anxiety disorder, and post-traumatic stress disorder. As a potent and highly specific agent, it functions by increasing serotonin levels in the central nervous system, which plays a critical role in mood regulation, emotional stability, and anxiety reduction. Its favorable pharmacokinetic profile and established efficacy make it a first-line pharmacological option in psychiatric and neurological therapeutics.
Paxil: Restore Emotional Balance with Trusted SSRI Therapy
Paxil (paroxetine hydrochloride) is a selective serotonin reuptake inhibitor (SSRI) antidepressant medication clinically proven to manage symptoms of major depressive disorder, anxiety disorders, and related conditions. Developed through rigorous pharmaceutical research, it works by increasing serotonin levels in the brain, helping restore chemical balance to improve mood, reduce anxiety, and enhance overall mental well-being. Trusted by healthcare professionals worldwide, Paxil represents a cornerstone in modern psychopharmacology with established efficacy and a well-documented safety profile when used as prescribed under medical supervision.
Pristiq: Targeted Serotonin-Norepinephrine Reuptake for Depression Relief
Pristiq (desvenlafaxine) is a serotonin-norepinephrine reuptake inhibitor (SNRI) approved by the FDA for the treatment of major depressive disorder (MDD) in adults. As the major active metabolite of venlafaxine, it offers a refined mechanism of action with a potentially favorable tolerability profile for many patients. This extended-release formulation is designed to provide steady-state plasma concentrations with once-daily dosing, supporting consistent therapeutic effect. Clinical studies demonstrate its efficacy in improving mood, energy levels, and interest in daily activities as part of a comprehensive treatment plan.
Zoloft: Effective SSRI Treatment for Major Depressive Disorder
Zoloft (sertraline HCl) is a selective serotonin reuptake inhibitor (SSRI) approved by the FDA for the treatment of major depressive disorder (MDD), obsessive-compulsive disorder (OCD), panic disorder, posttraumatic stress disorder (PTSD), social anxiety disorder, and premenstrual dysphoric disorder (PMDD). As a first-line pharmacological intervention, it works by increasing serotonin activity in the central nervous system, which helps restore chemical balance and improve mood, sleep, appetite, and energy levels. Its well-established efficacy, favorable safety profile, and extensive clinical history make it a cornerstone in modern psychiatric pharmacotherapy.
Abilify: Advanced Antipsychotic for Symptom Control and Stability
Abilify (aripiprazole) is an atypical antipsychotic medication engineered to provide a sophisticated mechanism of action for managing complex psychiatric conditions. It functions as a partial agonist, offering a unique modulatory effect on dopamine and serotonin receptors, which contributes to its efficacy and generally favorable tolerability profile. This medication is a cornerstone in the long-term management of schizophrenia, bipolar disorder, and as an adjunct in major depressive disorder, providing patients with a path toward sustained symptom control and improved functional outcomes.
Amitriptyline: Effective Relief for Chronic Pain and Depression
Amitriptyline is a tricyclic antidepressant (TCA) with a well-established profile for managing major depressive disorder and a range of chronic pain conditions. Its dual-action mechanism modulates serotonin and norepinephrine reuptake, offering both mood stabilization and central pain modulation. It is particularly valued in clinical practice for its efficacy in neuropathic pain, migraine prophylaxis, and as a second-line option for depression when SSRIs are ineffective or poorly tolerated. This product card provides a comprehensive, evidence-based overview for healthcare professionals.
Anafranil: Restoring Balance in Severe OCD Treatment
Anafranil (clomipramine hydrochloride) is a tricyclic antidepressant (TCA) with potent serotonin reuptake inhibition properties, specifically approved for the treatment of obsessive-compulsive disorder (OCD). It represents a foundational pharmacological intervention for moderate to severe OCD cases where first-line treatments prove insufficient. Its efficacy is well-documented in clinical literature, offering a robust option for patients struggling with intrusive thoughts and compulsive behaviors. By modulating key neurotransmitter systems, it helps reduce the core symptoms that significantly impair daily functioning and quality of life.
Asendin: Targeted Relief for Endogenous Depression with Dual-Action Efficacy
Asendin (amoxapine) is a tetracyclic antidepressant (TeCA) medication indicated for the relief of symptoms of endogenous depression. It represents a distinct class of agent that combines potent norepinephrine reuptake inhibition with secondary dopamine receptor blockade, offering a unique neurochemical profile for cases where first-line selective serotonin reuptake inhibitors (SSRIs) prove inadequate or intolerable. Its mechanism provides a rapid onset of action for certain symptoms, particularly psychomotor retardation, often within the first week of treatment.
Bupropion SR: Effective Relief for Major Depressive Disorder
Bupropion SR (sustained-release) is a widely prescribed antidepressant belonging to the aminoketone class, distinct from SSRIs and SNRIs. It functions primarily as a norepinephrine–dopamine reuptake inhibitor (NDRI), offering a unique mechanism of action for managing major depressive disorder. This formulation provides steady plasma concentrations over 12 hours, supporting consistent therapeutic effect with twice-daily dosing. Clinicians often favor bupropion SR for its favorable side effect profile, particularly the low incidence of sexual dysfunction and weight gain associated with other antidepressants.